Literature DB >> 3708226

How is ventilation maintained in the presence of the muscle relaxant, dantrolene sodium? A study in the anaesthetized rat.

R Farquhar, G C Leslie, N J Part.   

Abstract

The effects of intravenous injection of the muscle relaxant dantrolene sodium on ventilation, integrated EMG of external intercostal muscles and motor unit discharge in these muscles were measured in anaesthetized rats. Dantrolene sodium was administered in a carrier solution at pH 10. The carrier was not responsible for the effects seen on dantrolene sodium infusion. Dantrolene sodium (5 mg kg-1 body weight) reduced inspired ventilation (VI) on average from 308 +/- 106 ml min-1 (s.d., n = 8) in the control period to 247 +/- 118 ml min-1 (n = 8) after dantrolene sodium. Expired ventilation was reduced likewise from 274 +/- 132 ml min-1 (n = 8) to 229 +/- 109 ml min-1 (n = 8). These changes are significant at P less than 0.05. The integrated EMG was increased by 40.0 +/- 29.3% (n = 9), a change significant at P less than 0.001. Dantrolene sodium not only decreased the mean interspike interval of individual motor units by 16.2 +/- 11.1% (n = 13), a change significant at P less than 0.001, but also increased the duration of the burst of activity of each individual motor unit on average by 36.2 +/- 52.4% (n = 13), a change significant at P less than 0.05. The recruitment of additional motor units was also effected by dantrolene sodium. These units did not behave in any noticeably different manner from units previously active. It is concluded that the nervous system compensates for the effect of dantrolene sodium only to a limited extent by increasing the frequency of discharge of active motor units. Recruitment ofadditional motor units and increased burst duration play at least as important a role.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708226      PMCID: PMC1917100          DOI: 10.1111/j.1476-5381.1986.tb09473.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  The relation between force, velocity and integrated electrical activity in human muscles.

Authors:  B BIGLAND; O C LIPPOLD
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

2.  The relation between integrated action potentials in a human muscle and its isometric tension.

Authors:  O C J LIPPOLD
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

3.  Effects of dantrolene sodium on respiratory and other muscles and on respiratory parameters in the anaesthetised cat.

Authors:  W C Bowman; J Houston; H H Khan; I W Rodger
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

4.  Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors:  K O Ellis; S H Bryant
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Effects of intravenous dantrolene sodium on respiratory and cardiovascular functions.

Authors:  K O Ellis; F L Wessels; J F Carpenter
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

6.  The action of dantrolene sodium on individual fast and slow motor units of the rat anaesthetized with urethane.

Authors:  G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

7.  Mode of action of dantrolene sodium in spasticity.

Authors:  J Mai; E Pedersen
Journal:  Acta Neurol Scand       Date:  1979-06       Impact factor: 3.209

8.  The action of dantrolene sodium on rat fast and slow muscle in vivo.

Authors:  G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

9.  Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.

Authors:  E Knutsson; A Martensson
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

  9 in total
  5 in total

1.  The effect of dantrolene sodium on the discharge of alpha and gamma motoneurones to the soleus muscle in the decerebrate rat.

Authors:  R Farquhar; N J Part
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

Review 3.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

4.  Respiratory motor recovery after unilateral spinal cord injury: eliminating crossed phrenic activity decreases tidal volume and increases contralateral respiratory motor output.

Authors:  Francis J Golder; David D Fuller; Paul W Davenport; Richard D Johnson; Paul J Reier; Donald C Bolser
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

5.  The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat.

Authors:  G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.